What were the efficacy outcomes for topical roflumilast in Phase 3 clinical trials?
Featuring Mark Lebwohl, MD | Senior Clinical Advisor |
Dean for Clinical Therapeutics | Published August 30, 2022
Dean for Clinical Therapeutics
Kimberly and Eric J. Waldman Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY